Announced Fri, 7 Aug · 09:22 IST
Newspaper publication of Q1 FY27 unaudited financial results
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹54.23
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+3.3+5.0+1.4+2.2+0.5+2.3+9.3+4.6——
Up moveDown movePending
AI summary
Krebs Biochemicals published Q1 FY27 unaudited results in Business Standard and Prajasakti newspapers on August 7, 2026. Total income was Rs 714 lakhs versus Rs 549.26 lakhs in Q1 FY26. Net loss stood at Rs 248.48 lakhs versus Rs 532.43 lakhs in Q1 FY26 and Rs 233.96 lakhs in Q4 FY26. EPS was minus Rs 1.15. Results approved by Board on August 6.
Likely market impact
Year-over-year loss narrowed from Rs 532 lakhs to Rs 248 lakhs. Routine newspaper disclosure of already-approved results.